☰

Sid E. O'Bryant, Ph.D. - Publications

Affiliations: 
2004 State University of New York, Albany, Albany, NY, United States 
Area:
Clinical Neuropsychology
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

88/274 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Gavett BE, Ashendorf L, O'Bryant SE. When is it appropriate to infer cognitive impairment on the basis of premorbid IQ estimates? A simulation study. Psychological Assessment. PMID 34941355 DOI: 10.1037/pas0001101  0.771
2020 Petersen ME, Zhang F, Schupf N, Krinsky-McHale SJ, Hall J, Mapstone M, Cheema A, Silverman W, Lott I, Rafii MS, Handen B, Klunk W, Head E, Christian B, Foroud T, et al. Proteomic profiles for Alzheimer's disease and mild cognitive impairment among adults with Down syndrome spanning serum and plasma: An Alzheimer's Biomarker Consortium-Down Syndrome (ABC-DS) study. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12039. PMID 32626817 DOI: 10.1002/Dad2.12039  0.362
2020 Petersen M, Zhang F, Krinsky-McHale SJ, Silverman W, Lee JH, Pang D, Hall J, Schupf N, O'Bryant SE. Proteomic profiles of prevalent mild cognitive impairment and Alzheimer's disease among adults with Down syndrome. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12023. PMID 32435687 DOI: 10.1002/Dad2.12023  0.356
2019 Petersen ME, O'Bryant SE. Blood-based biomarkers for Down syndrome and Alzheimer's disease: A systematic review. Developmental Neurobiology. PMID 31389185 DOI: 10.1002/Dneu.22714  0.331
2019 Vintimilla R, Hall J, Johnson L, O'Bryant S. The relationship of CRP and cognition in cognitively normal older Mexican Americans: A cross-sectional study of the HABLE cohort. Medicine. 98: e15605. PMID 31083252 DOI: 10.1097/MD.0000000000015605  0.307
2019 Julovich D, Conger T, O'Bryant S, Hall JR. P1-262: AUTOMATED DIAGNOSTIC TESTING FOR DETECTION OF ALZHEIMER'S DISEASE Alzheimer's & Dementia. 15: P339-P340. DOI: 10.1016/J.Jalz.2019.06.817  0.313
2019 Vintimilla R, Johnson LA, Hall JR, O'Bryant S. P4-429: PREVALENCE OF RISK FACTORS RELATED TO CARDIOVASCULAR DISEASE AND COGNITION: A COMPARISON BETWEEN THE HABLE AND MHAS COHORTS Alzheimer's & Dementia. 15: P1467-P1467. DOI: 10.1016/J.Jalz.2019.06.4101  0.328
2018 Babulal GM, Quiroz YT, Albensi BC, Arenaza-Urquijo E, Astell AJ, Babiloni C, Bahar-Fuchs A, Bell J, Bowman GL, Brickman AM, Chételat G, Ciro C, Cohen AD, Dilworth-Anderson P, Dodge HH, et al. Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30555031 DOI: 10.1016/J.Jalz.2018.09.009  0.33
2018 Gavett BE, Stypulkowski K, Johnson L, Hall J, O'Bryant SE. Factor structure and measurement invariance of a neuropsychological test battery designed for assessment of cognitive functioning in older Mexican Americans. Alzheimer's & Dementia (Amsterdam, Netherlands). 10: 536-544. PMID 30364611 DOI: 10.1016/j.dadm.2018.08.003  0.633
2018 Hampel H, O'Bryant SE, Molinuevo JL, Zetterberg H, Masters CL, Lista S, Kiddle SJ, Batrla R, Blennow K. Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic. Nature Reviews. Neurology. PMID 30297701 DOI: 10.1038/S41582-018-0079-7  0.344
2018 Martins RN, Villemagne V, Sohrabi HR, Chatterjee P, Shah TM, Verdile G, Fraser P, Taddei K, Gupta VB, Rainey-Smith SR, Hone E, Pedrini S, Lim WL, Martins I, Frost S, et al. Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies. Journal of Alzheimer's Disease : Jad. 62: 965-992. PMID 29562546 DOI: 10.3233/Jad-171145  0.314
2017 Gupta VB, Hone E, Pedrini S, Doecke J, O'Bryant S, James I, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Martins RN. Altered levels of blood proteins in Alzheimer's disease longitudinal study: Results from Australian Imaging Biomarkers Lifestyle Study of Ageing cohort. Alzheimer's & Dementia (Amsterdam, Netherlands). 8: 60-72. PMID 28508031 DOI: 10.1016/J.Dadm.2017.04.003  0.326
2017 Large S, Johnson LA, O'Jile J, O'Bryant S, Hall JR. [P3-305]: THE RELATIONSHIP BETWEEN SUBJECTIVE MEMORY COMPLAINTS AND AFFECTIVE SYMPTOMS IN MEXICAN AMERICANS WITH MILD COGNITIVE IMPAIRMENT Alzheimer's & Dementia. 13: P1063-P1063. DOI: 10.1016/J.Jalz.2017.06.1520  0.352
2017 Hall JR, Wiechmann AR, Johnson LA, Edwards M, O'Bryant S. [P3-234]: THE RELATIONSHIP OF METABOLIC AND INFLAMMATORY BIOMARKERS TO SUBJECTIVE COGNITIVE COMPLAINTS IN A SAMPLE OF COGNITIVELY NORMAL MEXICAN-AMERICANS Alzheimer's & Dementia. 13: P1028-P1028. DOI: 10.1016/J.Jalz.2017.06.1447  0.346
2016 O'Bryant SE, Mielke MM, Rissman RA, Lista S, Vanderstichele H, Zetterberg H, Lewczuk P, Posner H, Hall J, Johnson L, Fong YL, Luthman J, Jeromin A, Batrla-Utermann R, Villarreal A, et al. Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27870940 DOI: 10.1016/J.Jalz.2016.09.014  0.303
2016 Johnson LA, Gamboa A, Vintimilla R, Edwards M, Hall J, Weiser B, Yadav M, Dickensheets T, O'Bryant SE. A Depressive Endophenotype for Predicting Cognitive Decline among Mexican American Adults and Elders. Journal of Alzheimer's Disease : Jad. PMID 27472872 DOI: 10.1016/J.Jalz.2015.06.992  0.364
2016 O'Bryant SE, Edwards M, Johnson L, Hall J, Villarreal AE, Britton GB, Quiceno M, Cullum CM, Graff-Radford NR. A blood screening test for Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 3: 83-90. PMID 27453929 DOI: 10.1016/J.Dadm.2016.06.004  0.317
2016 Villarreal AE, O'Bryant SE, Edwards M, Grajales S, Britton GB. Serum-based protein profiles of Alzheimer's disease and mild cognitive impairment in elderly Hispanics. Neurodegenerative Disease Management. PMID 27229914 DOI: 10.2217/Nmt-2015-0009  0.373
2016 Richardson JR, Graber J, Harris G, German DC, O'Bryant S, Shalat S. P3-190: Relationship between Serum Pesticide Levels and Cognitive Function in Elderly Individuals in the United States: Race/Ethnicity Differences Alzheimer's & Dementia. 12: P894-P894. DOI: 10.1016/J.Jalz.2016.06.2396  0.334
2016 Hall JR, Wiechmann AR, Johnson LA, Edwards M, Gamboa A, O'Bryant S. P3-326: The Relationship of Subjective Cognitive Concerns and Cognitive Functioning in a Sample of Cognitively Normal Mexican-American Adults Alzheimer's & Dementia. 12: P971-P971. DOI: 10.1016/J.Jalz.2016.06.1982  0.361
2016 Edwards M, Hall JR, Johnson LA, O'Bryant S. P3-149: Diagnosis of Diabetes Mellitus Does Not Differentially Impact the Proteomic Profile of Mild Cognitive Impairment Among Mexican Americans Alzheimer's & Dementia. 12: P876-P876. DOI: 10.1016/J.Jalz.2016.06.1809  0.302
2015 Edwards M, Hall J, Williams B, Johnson L, O'Bryant S. Molecular Markers of Amnestic Mild Cognitive Impairment among Mexican Americans. Journal of Alzheimer's Disease : Jad. 49: 221-8. PMID 26444793 DOI: 10.3233/Jad-150553  0.355
2015 Torrence ND, John SE, Gavett BE, O'Bryant SE. An Empirical Comparison of Competing Factor Structures for the Repeatable Battery for the Assessment of Neuropsychological Status: A Project FRONTIER Study. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. PMID 26429558 DOI: 10.1093/arclin/acv057  0.584
2015 Lista S, Molinuevo JL, Cavedo E, Rami L, Amouyel P, Teipel SJ, Garaci F, Toschi N, Habert MO, Blennow K, Zetterberg H, O'Bryant SE, Johnson L, Galluzzi S, Bokde AL, et al. Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline. Journal of Alzheimer's Disease : Jad. PMID 26402088 DOI: 10.3233/Jad-150202  0.382
2015 Lista S, O'Bryant SE, Blennow K, Dubois B, Hugon J, Zetterberg H, Hampel H. Biomarkers in Sporadic and Familial Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. 47: 291-317. PMID 26401553 DOI: 10.3233/Jad-143006  0.312
2015 Jahn DR, Dressel JA, Gavett BE, O'Bryant SE. An item response theory analysis of the Executive Interview and development of the EXIT8: A Project FRONTIER Study. Journal of Clinical and Experimental Neuropsychology. 37: 229-42. PMID 25748691 DOI: 10.1080/13803395.2014.1002757  0.598
2015 Laske C, Sohrabi HR, Frost SM, López-de-Ipiña K, Garrard P, Buscema M, Dauwels J, Soekadar SR, Mueller S, Linnemann C, Bridenbaugh SA, Kanagasingam Y, Martins RN, O'Bryant SE. Innovative diagnostic tools for early detection of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 561-78. PMID 25443858 DOI: 10.1016/J.Jalz.2014.06.004  0.353
2015 Johnson LA, Sohrabi HR, Hall JR, Kevin T, Edwards M, O'Bryant SE, Martins RN. A depressive endophenotype of poorer cognition among cognitively healthy community-dwelling adults: results from the Western Australia memory study. International Journal of Geriatric Psychiatry. 30: 881-6. PMID 25394326 DOI: 10.1002/Gps.4231  0.373
2015 O'Bryant SE, Gupta V, Henriksen K, Edwards M, Jeromin A, Lista S, Bazenet C, Soares H, Lovestone S, Hampel H, Montine T, Blennow K, Foroud T, Carrillo M, Graff-Radford N, et al. Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 549-60. PMID 25282381 DOI: 10.1016/J.Jalz.2014.08.099  0.333
2015 Edwards M, Johnson LA, Hall J, O'Bryant S. P3-069: Molecular markers of amnestic and nonamnestic mild cognitive impairment among mexican americans: A molecular neuropsychology approach Alzheimer's & Dementia. 11: P643-P643. DOI: 10.1016/J.Jalz.2015.06.936  0.323
2015 Hall J, Wiechmann AR, Edwards M, Johnson LA, O'Bryant S. P3-065: Association of biomarkers of vascular risk and inflammation to cognitive performance in mexican-american women: A hable study Alzheimer's & Dementia. 11: P642-P642. DOI: 10.1016/J.Jalz.2015.06.932  0.329
2014 O'Bryant SE, Xiao G, Zhang F, Edwards M, German DC, Yin X, Como T, Reisch J, Huebinger RM, Graff-Radford N, Dickson D, Barber R, Hall J, O'Suilleabhain P, Grammas P. Validation of a serum screen for Alzheimer's disease across assay platforms, species, and tissues. Journal of Alzheimer's Disease : Jad. 42: 1325-35. PMID 25024345 DOI: 10.3233/Jad-141041  0.305
2014 Edwards M, Balldin VH, Hall J, O'Bryant S. Combining select neuropsychological assessment with blood-based biomarkers to detect mild Alzheimer's disease: a molecular neuropsychology approach. Journal of Alzheimer's Disease : Jad. 42: 635-40. PMID 24916542 DOI: 10.3233/Jad-140852  0.367
2014 Cunningham RL, Singh M, O'Bryant SE, Hall JR, Barber RC. Oxidative stress, testosterone, and cognition among Caucasian and Mexican-American men with and without Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 40: 563-73. PMID 24496073 DOI: 10.3233/Jad-131994  0.308
2014 Snyder HM, Carrillo MC, Grodstein F, Henriksen K, Jeromin A, Lovestone S, Mielke MM, O'Bryant S, Sarasa M, Sjøgren M, Soares H, Teeling J, Trushina E, Ward M, West T, et al. Developing novel blood-based biomarkers for Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 109-14. PMID 24365657 DOI: 10.1016/J.Jalz.2013.10.007  0.312
2014 Johnson LA, Cushing B, Rohlfing G, Edwards M, Davenloo H, D'Agostino D, Hall JR, O'Bryant SE. The Hachinski ischemic scale and cognition: the influence of ethnicity. Age and Ageing. 43: 364-9. PMID 24321843 DOI: 10.1093/Ageing/Aft189  0.381
2014 Falkowski J, Atchison T, Debutte-Smith M, Weiner MF, O'Bryant S. Executive functioning and the metabolic syndrome: a project FRONTIER study. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 29: 47-53. PMID 24152591 DOI: 10.1093/Arclin/Act078  0.312
2014 O'Bryant SE, Xiao G, Barber R, Cullum CM, Weiner M, Hall J, Edwards M, Grammas P, Wilhelmsen K, Doody R, Diaz-Arrastia R. Molecular neuropsychology: creation of test-specific blood biomarker algorithms. Dementia and Geriatric Cognitive Disorders. 37: 45-57. PMID 24107792 DOI: 10.1159/000345605  0.339
2014 Hall JR, Edwards M, Barber RC, O'Bryant S. P3-081: GLP-1 AND DELAYED MEMORY PERFORMANCE AMONG MILD COGNITIVE IMPAIRMENT CASES WITH AND WITHOUT DIABETES MELLITUS Alzheimer's & Dementia. 10: P656-P657. DOI: 10.1016/J.Jalz.2014.05.1169  0.311
2013 Jahn DR, Mauer CB, Menon CV, Edwards ML, Dressel JA, O'Bryant SE. A brief Spanish-English equivalent version of the Boston Naming Test: a Project FRONTIER study. Journal of Clinical and Experimental Neuropsychology. 35: 835-45. PMID 23998641 DOI: 10.1080/13803395.2013.825234  0.763
2013 Menon C, Westervelt HJ, Jahn DR, Dressel JA, O'Bryant SE. Normative performance on the Brief Smell Identification Test (BSIT) in a multi-ethnic bilingual cohort: a Project FRONTIER study. The Clinical Neuropsychologist. 27: 946-61. PMID 23634698 DOI: 10.1080/13854046.2013.796406  0.783
2013 O'Bryant SE, Johnson L, Edwards M, Soares H, Devous MD, Ross S, Rohlfing G, Hall J. The link between C-reactive protein and Alzheimer's disease among Mexican Americans. Journal of Alzheimer's Disease : Jad. 34: 701-6. PMID 23254637 DOI: 10.3233/Jad-122071  0.331
2013 Menon CV, Jahn DR, Mauer CB, O'Bryant SE. Executive functioning as a mediator of the relationship between premorbid verbal intelligence and health risk behaviors in a rural-dwelling cohort: a Project FRONTIER study. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 28: 169-79. PMID 23192834 DOI: 10.1093/Arclin/Acs102  0.757
2013 Johnson LA, Mauer C, Jahn D, Song M, Wyshywaniuk L, Hall JR, Balldin VH, O'Bryant SE. Cognitive differences among depressed and non-depressed MCI participants: a project FRONTIER study. International Journal of Geriatric Psychiatry. 28: 377-82. PMID 22653735 DOI: 10.1002/Gps.3835  0.33
2013 Devous M, Fatt CC, Abdi H, Harris T, Hynanc L, O'Bryant S. O4-03-04: Delineating the relationship between cognitive measures and functional connectivity in Alzheimer's disease Alzheimer's & Dementia. 9: P685-P685. DOI: 10.1016/J.Jalz.2013.04.349  0.348
2012 Balldin VH, Hall JR, Barber RC, Hynan L, Diaz-Arrastia R, O'Bryant SE. The Relation between Inflammation and Neuropsychological Test Performance. International Journal of Alzheimer's Disease. 2012: 703871. PMID 23008797 DOI: 10.1155/2012/703871  0.324
2012 Spering CC, Hobson V, Lucas JA, Menon CV, Hall JR, O'Bryant SE. Diagnostic accuracy of the MMSE in detecting probable and possible Alzheimer's disease in ethnically diverse highly educated individuals: an analysis of the NACC database. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 67: 890-6. PMID 22396476 DOI: 10.1093/gerona/gls006  0.758
2012 Pedraza O, Clark JH, O'Bryant SE, Smith GE, Ivnik RJ, Graff-Radford NR, Willis FB, Petersen RC, Lucas JA. Diagnostic validity of age and education corrections for the Mini-Mental State Examination in older African Americans. Journal of the American Geriatrics Society. 60: 328-31. PMID 22150301 DOI: 10.1111/J.1532-5415.2011.03766.X  0.343
2012 Menon C, Hall J, Hobson V, Johnson L, O'Bryant SE. Normative performance on the executive clock drawing task in a multi-ethnic bilingual cohort: a project FRONTIER study. International Journal of Geriatric Psychiatry. 27: 959-66. PMID 22052628 DOI: 10.1002/Gps.2810  0.769
2012 Edwards M, Hall J, O'Bryant S. P2-165: Higher vanadium levels differentially impacted neuropsychological functioning in cases of normal cognition and mild cognitive impairment: A project FRONTIER study Alzheimer's & Dementia. 8: P316-P316. DOI: 10.1016/J.Jalz.2012.05.871  0.354
2012 Edwards M, Hall J, O'Bryant S. P1-120: Higher groundwater vanadium levels are associated with better cognitive functioning in a sample of cases with diabetes mellitus: A Project FRONTIER study Alzheimer's & Dementia. 8: P148-P148. DOI: 10.1016/J.Jalz.2012.05.397  0.327
2011 Hall JR, O'Bryant SE, Johnson LA, Barber RC. Depressive symptom clusters and neuropsychological performance in mild Alzheimer's and cognitively normal elderly. Depression Research and Treatment. 2011: 396958. PMID 21904674 DOI: 10.1155/2011/396958  0.403
2011 O'Bryant SE, Xiao G, Barber R, Reisch J, Hall J, Cullum CM, Doody R, Fairchild T, Adams P, Wilhelmsen K, Diaz-Arrastia R. A blood-based algorithm for the detection of Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 32: 55-62. PMID 21865746 DOI: 10.1159/000330750  0.313
2011 Johnson LA, Hobson V, Jenkins M, Dentino A, Ragain RM, O'Bryant S. The influence of thyroid function on cognition in a sample of ethnically diverse, rural-dwelling women: a project FRONTIER study. The Journal of Neuropsychiatry and Clinical Neurosciences. 23: 219-22. PMID 21677255 DOI: 10.1176/Jnp.23.2.Jnp219  0.37
2011 O'Bryant SE, Edwards M, Menon CV, Gong G, Barber R. Long-term low-level arsenic exposure is associated with poorer neuropsychological functioning: a Project FRONTIER study. International Journal of Environmental Research and Public Health. 8: 861-74. PMID 21556183 DOI: 10.3390/ijerph8030861  0.763
2011 Duff K, Spering CC, O'Bryant SE, Beglinger LJ, Moser DJ, Bayless JD, Culp KR, Mold JW, Adams RL, Scott JG. The RBANS Effort Index: base rates in geriatric samples. Applied Neuropsychology. 18: 11-7. PMID 21390895 DOI: 10.1080/09084282.2010.523354  0.563
2011 O'Bryant SE, Hobson VL, Hall JR, Barber RC, Zhang S, Johnson L, Diaz-Arrastia R. Serum brain-derived neurotrophic factor levels are specifically associated with memory performance among Alzheimer's disease cases. Dementia and Geriatric Cognitive Disorders. 31: 31-6. PMID 21135555 DOI: 10.1159/000321980  0.308
2011 Wiechmann A, Hall JR, O'Bryant SE. The utility of the spatial span in a clinical geriatric population. Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition. 18: 56-63. PMID 20924826 DOI: 10.1080/13825585.2010.510556  0.378
2011 Hobson VL, Hall JR, Harvey M, Cullum CM, Lacritz L, Massman PJ, Waring SC, O'Bryant SE. An examination of the Boston Naming Test: calculation of "estimated" 60-item score from 30- and 15-item scores in a cognitively impaired population. International Journal of Geriatric Psychiatry. 26: 351-5. PMID 20690129 DOI: 10.1002/Gps.2533  0.37
2011 O'Bryant SE, Hall JR, Cukrowicz KC, Edwards M, Johnson LA, Lefforge D, Jenkins M, Dentino A. The differential impact of depressive symptom clusters on cognition in a rural multi-ethnic cohort: a Project FRONTIER study. International Journal of Geriatric Psychiatry. 26: 199-205. PMID 20661882 DOI: 10.1002/Gps.2514  0.398
2011 Hall JR, O'Bryant SE, Johnson L, Barber RC. Depression and Brain-derived Neurotrophic Factor Levels in Alzheimer's Disease Neuroscience and Medicine. 2: 43-47. DOI: 10.4236/Nm.2011.21006  0.305
2011 Royall DR, Doody R, Barber R, Palmer R, O'Bryant S, Reisch J, Fairchild T, Adams P. The Cognitive Correlates of Functional Status: A New Approach to Dementia Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.484  0.34
2010 Duff K, Hobson VL, Beglinger LJ, O'Bryant SE. Diagnostic accuracy of the RBANS in mild cognitive impairment: limitations on assessing milder impairments. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 25: 429-41. PMID 20570820 DOI: 10.1093/Arclin/Acq045  0.609
2010 O'Bryant SE, Waring SC, Hobson V, Hall JR, Moore CB, Bottiglieri T, Massman P, Diaz-Arrastia R. Decreased C-reactive protein levels in Alzheimer disease. Journal of Geriatric Psychiatry and Neurology. 23: 49-53. PMID 19933496 DOI: 10.1177/0891988709351832  0.322
2009 Duff K, O'Bryant SE, Westervelt HJ, Sweet JJ, Reynolds CR, van Gorp WG, Tranel D, McCaffrey RJ. On becoming a peer reviewer for a neuropsychology journal. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 24: 201-7. PMID 19640873 DOI: 10.1093/Arclin/Acp031  0.636
2009 O'Bryant SE, Hobson V, Hall JR, Waring SC, Chan W, Massman P, Lacritz L, Cullum CM, Diaz-Arrastia R. Brain-derived neurotrophic factor levels in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 17: 337-41. PMID 19363274 DOI: 10.3233/Jad-2009-1051  0.348
2008 Duff K, Humphreys Clark JD, O'Bryant SE, Mold JW, Schiffer RB, Sutker PB. Utility of the RBANS in detecting cognitive impairment associated with Alzheimer's disease: sensitivity, specificity, and positive and negative predictive powers. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 23: 603-12. PMID 18639437 DOI: 10.1016/J.Acn.2008.06.004  0.618
2008 O'Bryant SE, Humphreys JD, Smith GE, Ivnik RJ, Graff-Radford NR, Petersen RC, Lucas JA. Detecting dementia with the mini-mental state examination in highly educated individuals. Archives of Neurology. 65: 963-7. PMID 18625866 DOI: 10.1001/Archneur.65.7.963  0.336
2008 O'Bryant SE, Gavett BE, McCaffrey RJ, O'Jile JR, Huerkamp JK, Smitherman TA, Humphreys JD. Clinical utility of Trial 1 of the Test of Memory Malingering (TOMM). Applied Neuropsychology. 15: 113-6. PMID 18568603 DOI: 10.1080/09084280802083921  0.703
2008 O'Bryant S. Exploring the relation between culture and cognition Journal of Clinical and Experimental Neuropsychology. 30: 967-970. DOI: 10.1080/13803390801937175  0.307
2007 O'Bryant SE, Humphreys JD, Bauer L, McCaffrey RJ, Hilsabeck RC. The influence of ethnicity on Symbol Digit Modalities Test performance: an analysis of a multi-ethnic college and hepatitis C patient sample. Applied Neuropsychology. 14: 183-8. PMID 17848129 DOI: 10.1080/09084280701508986  0.558
2007 Bauer L, O'Bryant SE, Lynch JK, McCaffrey RJ, Fisher JM. Examining the Test Of Memory Malingering Trial 1 and Word Memory Test Immediate Recognition as screening tools for insufficient effort. Assessment. 14: 215-22. PMID 17690378 DOI: 10.1177/1073191106297617  0.567
2007 O'Bryant SE, Engel LR, Kleiner JS, Vasterling JJ, Black FW. Test of memory malingering (TOMM) trial 1 as a screening measure for insufficient effort. The Clinical Neuropsychologist. 21: 511-21. PMID 17455034 DOI: 10.1080/13854040600611368  0.36
2007 O'Bryant SE, Lucas JA, Willis FB, Smith GE, Graff-Radford NR, Ivnik RJ. Discrepancies between self-reported years of education and estimated reading level among elderly community-dwelling African-Americans: Analysis of the MOAANS data. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 22: 327-32. PMID 17336494 DOI: 10.1016/J.Acn.2007.01.007  0.309
2006 O'Bryant SE, McCaffrey RJ. Preliminary findings on the Cross Cultural Test Of Face Recognition. Applied Neuropsychology. 13: 223-9. PMID 17362142 DOI: 10.1207/S15324826An1304_3  0.597
2006 O'Bryant SE, Lucas JA. Estimating the predictive value of the Test of Memory Malingering: an illustrative example for clinicians. The Clinical Neuropsychologist. 20: 533-40. PMID 16895864 DOI: 10.1080/13854040590967568  0.336
2006 Large S, O'Jile J, Hall JR, O'Bryant S, Johnson LA. P3-498: CHARACTERIZATION OF WORRY AND COGNITION IN MEXICAN AMERICAN WOMEN Alzheimer's & Dementia. 14: P1313-P1313. DOI: 10.1016/J.Jalz.2018.06.1862  0.307
2006 Hall JR, Johnson LA, Wiechmann AR, Edwards M, O'Bryant S. P3-324: CHARACTERISTICS OF COGNITIVELY NORMAL OLDER MEXICAN AMERICANS AND NON-HISPANIC WHITES WITH SUBJECTIVE COGNITIVE COMPLAINTS Alzheimer's & Dementia. 14: P1205-P1205. DOI: 10.1016/J.Jalz.2018.06.1685  0.347
2006 O'Jile J, Large S, O'Bryant S, Hall JR, Johnson LA. P2-554: CHARACTERIZATION OF WORRY AND ITS EFFECT ON COGNITION IN MEXICAN AMERICAN WOMEN Alzheimer's & Dementia. 14: P949-P949. DOI: 10.1016/J.Jalz.2018.06.1249  0.309
2005 O'Bryant SE, Marcus DA, Rains JC, Penzien DB. Neuropsychology of migraine: present status and future directions. Expert Review of Neurotherapeutics. 5: 363-70. PMID 15938669 DOI: 10.1586/14737175.5.3.363  0.357
2005 Gavett BE, O'Bryant SE, Fisher JM, McCaffrey RJ. Hit rates of adequate performance based on the test of memory malingering (TOMM) Trial 1. Applied Neuropsychology. 12: 1-4. PMID 15788216 DOI: 10.1207/S15324826An1201_1  0.707
2004 O'Bryant SE, O'Jile JR, McCaffrey RJ. Reporting of demographic variables in neuropsychological research: trends in the current literature. The Clinical Neuropsychologist. 18: 229-33. PMID 15587670 DOI: 10.1080/13854040490501439  0.521
2004 O'Bryant SE, Duff K, Fisher J, McCaffrey RJ. Performance profiles and cut-off scores on the Memory Assessment Scales. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 19: 489-96. PMID 15163450 DOI: 10.1016/J.Acn.2003.07.001  0.671
2003 O'Bryant SE, Hilsabeck RC, McCaffrey RJ, Drew Gouvier W. The Recognition Memory Test Examination of ethnic differences and norm validity. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 18: 135-43. PMID 14591465 DOI: 10.1016/S0887-6177(01)00189-5  0.552
2003 O'Bryant SE, Palav A, McCaffrey RJ. A review of symptoms commonly associated with menopause: implications for clinical neuropsychologists and other health care providers. Neuropsychology Review. 13: 145-52. PMID 14584909 DOI: 10.1023/A:1025573529407  0.731
2003 Ashendorf L, O'Bryant SE, McCaffrey RJ. Specificity of malingering detection strategies in older adults using the CVLT and WCST. The Clinical Neuropsychologist. 17: 255-62. PMID 13680433 DOI: 10.1076/Clin.17.2.255.16502  0.751
2003 O'Bryant SE, Hilsabeck RC, Fisher JM, McCaffrey RJ. Utility of the trail making test in the assessment of malingering in a sample of mild traumatic brain injury litigants. The Clinical Neuropsychologist. 17: 69-74. PMID 12854012 DOI: 10.1076/Clin.17.1.69.15624  0.547
2003 McCaffrey RJ, O'Bryant SE, Ashendorf L, Fisher JM. Correlations among the TOMM, Rey-15, and MMPI-2 validity scales in a sample of TBI litigants Journal of Forensic Neuropsychology. 3: 45-53. DOI: 10.1300/J151v03n03_03  0.731
Low-probability matches (unlikely to be authored by this person)
2013 O'Bryant SE, Johnson L, Balldin V, Edwards M, Barber R, Williams B, Devous M, Cushings B, Knebl J, Hall J. Characterization of Mexican Americans with mild cognitive impairment and Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 33: 373-9. PMID 22976076 DOI: 10.3233/JAD-2012-121420  0.299
2013 Hall JR, Wiechmann AR, Johnson LA, Edwards M, Barber RC, Winter AS, Singh M, O'Bryant SE. Biomarkers of vascular risk, systemic inflammation, and microvascular pathology and neuropsychiatric symptoms in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 35: 363-71. PMID 23403534 DOI: 10.3233/Jad-122359  0.298
2010 Clark JH, Hobson VL, O'Bryant SE. Diagnostic accuracy of percent retention scores on RBANS verbal memory subtests for the diagnosis of Alzheimer's disease and mild cognitive impairment. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 25: 318-26. PMID 20378680 DOI: 10.1093/arclin/acq023  0.297
2016 O'Bryant SE, Lista S, Rissman RA, Edwards M, Zhang F, Hall J, Zetterberg H, Lovestone S, Gupta V, Graff-Radford N, Martins R, Jeromin A, Waring S, Oh E, King M, et al. Comparing biological markers of Alzheimer's disease across blood fraction and platforms: Comparing apples to oranges. Alzheimer's & Dementia (Amsterdam, Netherlands). 3: 27-34. PMID 27019866 DOI: 10.1016/J.Dadm.2015.12.003  0.297
2015 Barber RC, Phillips NR, Tilson JL, Huebinger RM, Shewale SJ, Koenig JL, Mitchel JS, O'Bryant SE, Waring SC, Diaz-Arrastia R, Chasse S, Wilhelmsen KC. Can Genetic Analysis of Putative Blood Alzheimer's Disease Biomarkers Lead to Identification of Susceptibility Loci? Plos One. 10: e0142360. PMID 26625115 DOI: 10.1371/Journal.Pone.0142360  0.296
2016 Dubois B, Hampel H, Feldman HH, Scheltens P, Aisen P, Andrieu S, Bakardjian H, Benali H, Bertram L, Blennow K, Broich K, Cavedo E, Crutch S, Dartigues JF, Duyckaerts C, et al. Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 12: 292-323. PMID 27012484 DOI: 10.1016/J.Jalz.2016.02.002  0.296
2012 Hall J, Johnson L, Wiechmann A, Barber R, Winter S, O'Bryant S. P1-030: Biomarkers of depressive symptoms in Alzheimer's disease: Gender differences Alzheimer's & Dementia. 8: P117-P117. DOI: 10.1016/J.Jalz.2012.05.305  0.295
2013 O'Bryant S, German D, Xiao G, Zhang F, Como T, O'Suilleabhain P, Edwards M, Williams B, Hall J, Barber R. P1-232: Validation of a serum-based screen for Alzheimer's disease Alzheimer's & Dementia. 9: P237-P238. DOI: 10.1016/J.Jalz.2013.05.456  0.294
2011 Hall JR, Harvey M, Vo HT, O'Bryant SE. Performance on a measure of category fluency in cognitively impaired elderly. Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition. 18: 353-61. PMID 21390875 DOI: 10.1080/13825585.2011.557495  0.293
2017 Johnson LA, Munoz HI, Large S, O'Jile J, Hall JR, O'Bryant S. [P1-318]: THE RELATIONSHIP BETWEEN UNCONTROLLED DIABETES AND COGNITION IN MEXICAN AMERICAN ELDERS Alzheimer's & Dementia. 13: P376-P376. DOI: 10.1016/J.Jalz.2017.06.334  0.292
2012 Hall J, Johnson L, Wiechmann A, Barber R, Winter S, O'Bryant S. P1-031: Relationship of biomarkers of cardiovascular risk and systemic inflammation to neuropsychiatric symptoms in Alzheimer's disease Alzheimer's & Dementia. 8: P118-P118. DOI: 10.1016/J.Jalz.2012.05.306  0.292
2011 O'Bryant S, Xiao G, Barber R, Hall J, Doody R, Reisch J, Fairchild T, Adams P, Royall D, Wilhelmsen K, Diaz-Arrastia R. P2-055: Refinement and expansion of the Texas Alzheimer's research consortium serum-based diagnostic algorithm for Alzheimer's disease Alzheimer's & Dementia. 7: S325-S325. DOI: 10.1016/J.Jalz.2011.05.944  0.29
2019 Large SE, Johnson LA, O'Jile J, Moss K, Hall JR, O'Bryant S. P4-373: IMPACT OF PHYSICAL ACTIVITY ON COGNITION IN OLDER MEXICAN AMERICANS WITH DIABETES Alzheimer's & Dementia. 15: P1443-P1443. DOI: 10.1016/J.Jalz.2019.06.4044  0.289
2020 Chaudhari K, Wong JM, Vann PH, Como T, O'Bryant SE, Sumien N. ApoE Genotype-Dependent Response to Antioxidant and Exercise Interventions on Brain Function. Antioxidants (Basel, Switzerland). 9. PMID 32630431 DOI: 10.3390/Antiox9060553  0.287
2011 Xiao G, Barber R, Reisch J, Doody R, Fairchild T, Adams P, Royall D, Diaz-Arrastia R, O'Bryant S. P2-085: Developing and validating of Diagnostic Algorithm for Alzheimer's Disease Alzheimer's & Dementia. 7: S334-S335. DOI: 10.1016/J.Jalz.2011.05.975  0.286
2017 O'Bryant S. HEALTH DISPARITIES IN ALZHEIMER'S DISEASE AMONG MEXICAN AMERICANS Alzheimer's & Dementia. 13: P1450. DOI: 10.1016/J.Jalz.2017.07.500  0.283
2011 Doody R, Chan W, Ballantyne C, Pavlik V, Barber R, O'Bryant S, Darby E, Diaz-Arrastia R, Fairchild T, Royall D, Adams P. Biomarkers associated with cardiovascular risk in the texas Alzheimer's Disease Research and Care Consortium (TARCC) Cohort: LpPla2 and Homocysteine Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.921  0.282
2023 Grasso SM, Clark AL, Petersen M, O'Bryant S. Bilingual neurocognitive resiliency, vulnerability, and Alzheimer's disease biomarker correlates in Latino older adults enrolled in the Health and Aging Brain Study - Health Disparities (HABS-HD). Alzheimer's & Dementia (Amsterdam, Netherlands). 15: e12509. PMID 38089652 DOI: 10.1002/dad2.12509  0.282
2020 Vintimilla R, Reyes M, Johnson L, Hall J, O'Bryant S. Cardiovascular risk factors in Mexico and the United States: a comparative cross-sectional study between the HABLE and MHAS participants. Gaceta Medica De Mexico. 156: 17-21. PMID 32026882 DOI: 10.24875/Gmm.19005350  0.279
2017 Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, Kunkle BW, Boland A, Raybould R, Bis JC, Martin ER, Grenier-Boley B, Heilmann-Heimbach S, Chouraki V, Kuzma AB, et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nature Genetics. PMID 28714976 DOI: 10.1038/Ng.3916  0.279
2005 Schrimsher GW, O'Bryant SE, Parker JD, Burke RS. The relation between ethnicity and cognistat performance in males seeking substance use disorder treatment. Journal of Clinical and Experimental Neuropsychology. 27: 873-85. PMID 16183620 DOI: 10.1080/13803390490919173  0.279
2012 Cukrowicz KC, Jahn DR, Hall J, O'Bryant S. Psychological symptoms and blood pressure among rural-dwellers. Journal of Health Psychology. 17: 1203-11. PMID 22274746 DOI: 10.1177/1359105311427474  0.279
2023 Gonzales MM, Vela G, Philip V, Trevino H, LaRoche A, Wang CP, Parent DM, Kautz T, Satizabal CL, Tanner J, O'Bryant S, Maestre G, Tracy RP, Seshadri S. Demographic and Clinical Characteristics Associated With Serum GFAP Levels in an Ethnically Diverse Cohort. Neurology. 101: e1531-e1541. PMID 37813589 DOI: 10.1212/WNL.0000000000207706  0.279
2014 German D, O'Suilleabhain P, Zhang F, O'Bryant S. P1-131: ALZHEIMER'S DISEASE AND PARKINSON's DISEASE: BLOOD BIOMARKER DIFFERENCES Alzheimer's & Dementia. 10: P348-P348. DOI: 10.1016/J.Jalz.2014.05.368  0.278
2021 Garcia JM, Gallagher MW, O'Bryant SE, Medina LD. Differential item functioning of the Beck Anxiety Inventory in a rural, multi-ethnic cohort. Journal of Affective Disorders. 293: 36-42. PMID 34166907 DOI: 10.1016/j.jad.2021.06.005  0.278
2019 Munoz HI, Large SE, Wong L, Ruiz D, Hall JR, O'Bryant S, Johnson LA. P1-543: Ethnic Differences In Recruitment Of Older Adults Into Aging Research Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.1148  0.278
2014 Hall JR, Wiechmann A, Johnson L, Edwards M, Barber R, O'Bryant SE. F5-02-04: BLOOD-BASED BIOMARKERS OF NEUROPSYCHIATRIC SYMPTOMS IN ALZHEIMER'S: INFLAMMATION, VASCULAR RISKS, GENDER, AND APOE-E4 STATUS Alzheimer's & Dementia. 10: P284-P284. DOI: 10.1016/J.Jalz.2014.04.464  0.277
2014 Edwards M, Hall J, Gong G, O'Bryant SE. Arsenic exposure, AS3MT polymorphism, and neuropsychological functioning among rural dwelling adults and elders: a cross-sectional study. Environmental Health : a Global Access Science Source. 13: 15. PMID 24621105 DOI: 10.1186/1476-069X-13-15  0.277
2017 Johnson LA, Edwards M, Gamboa A, Hall J, Robinson M, O'Bryant SE. Depression, inflammation, and memory loss among Mexican Americans: analysis of the HABLE cohort. International Psychogeriatrics. 1-7. PMID 28629481 DOI: 10.1017/S1041610217001016  0.277
2013 Edwards M, Como T, Johnson L, Hall J, Barber R, Laske C, Graff-Radford N, Devous M, O'Bryant S. P1-229: sTNF-R1 as a biomarker of Alzheimer's disease varies by APOE-ε4 status Alzheimer's & Dementia. 9: P236-P236. DOI: 10.1016/J.Jalz.2013.05.453  0.276
2010 O'Bryant SE, Lacritz LH, Hall J, Waring SC, Chan W, Khodr ZG, Massman PJ, Hobson V, Cullum CM. Validation of the new interpretive guidelines for the clinical dementia rating scale sum of boxes score in the national Alzheimer's coordinating center database. Archives of Neurology. 67: 746-9. PMID 20558394 DOI: 10.1001/Archneurol.2010.115  0.275
2011 Wilhelmsen K, Chasse S, Griffin N, Diaz-Arrastia R, Barber R, Royall D, O'Bryant S, Doody R, Fairchild T, Rosenberg RN, Adams P, Reisch J. P2-088: Genome-Wide association scan replication for biomarker endophenotypes of Alzheimer's disease Alzheimer's & Dementia. 7: S335-S336. DOI: 10.1016/J.Jalz.2011.05.978  0.275
2018 O'Bryant SE, Zhang F, Johnson LA, Hall J, Edwards M, Grammas P, Oh E, Lyketsos CG, Rissman RA. A Precision Medicine Model for Targeted NSAID Therapy in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 30198872 DOI: 10.3233/Jad-180619  0.274
2013 Edwards M, Barber R, Johnson L, Hall J, Xiao G, Rohlfing G, Devous M, Graff-Radford N, O'Bryant S. P1-237: Thrombopoietin and Alzheimer's disease Alzheimer's & Dementia. 9: P239-P239. DOI: 10.1016/J.Jalz.2013.05.461  0.272
2019 O'Bryant SE, Ferman TJ, Zhang F, Hall J, Pedraza O, Wszolek ZK, Como T, Julovich D, Mattevada S, Johnson LA, Edwards M, Hall J, Graff-Radford NR. A proteomic signature for dementia with Lewy bodies. Alzheimer's & Dementia (Amsterdam, Netherlands). 11: 270-276. PMID 30923734 DOI: 10.1016/J.Dadm.2019.01.006  0.271
2010 O'Bryant SE, Xiao G, Barber R, Reisch J, Doody R, Fairchild T, Adams P, Waring S, Diaz-Arrastia R. A serum protein-based algorithm for the detection of Alzheimer disease. Archives of Neurology. 67: 1077-81. PMID 20837851 DOI: 10.1001/Archneurol.2010.215  0.27
2012 Gong G, O'Bryant SE. Low-level arsenic exposure, AS3MT gene polymorphism and cardiovascular diseases in rural Texas counties. Environmental Research. 113: 52-7. PMID 22341486 DOI: 10.1016/J.Envres.2012.01.003  0.27
2012 Warren MW, Hynan LS, Weiner MF, Doody R, Rountree S, Capriles V, Ballantyne C, Darby E, Dawson T, Hittle A, Khaleeg A, O'Bryant S, Grammas P, Williams B, Wu CK, et al. Lipids and adipokines as risk factors for Alzheimer's disease Journal of Alzheimer's Disease. 29: 151-157. PMID 22232009 DOI: 10.3233/Jad-2012-111385  0.269
2016 Villarreal AE, Grajales S, O'Bryant SE, Edwards M, López L, Montalván A, Britton GB. Characterization of Alzheimer's Disease and Mild Cognitive Impairment in Older Adults in Panama. Journal of Alzheimer's Disease : Jad. PMID 27567849 DOI: 10.3233/JAD-160402  0.267
2022 Vintimilla R, Nevin T, Hall J, Johnson L, O'Bryant S. Cardiovascular Risk Factors and Cognitive Performance in Cognitively Normal Non-Hispanic Whites and Mexican Americans From the HABS-HD Cohort. Gerontology & Geriatric Medicine. 8: 23337214221142958. PMID 36518808 DOI: 10.1177/23337214221142958  0.267
2012 Royall DR, Palmer RF, O'Bryant SE. Validation of a latent variable representing the dementing process. Journal of Alzheimer's Disease : Jad. 30: 639-49. PMID 22451315 DOI: 10.3233/JAD-2012-120055  0.264
2023 Wong CG, Miller JB, Zhang F, Rissman RA, Raman R, Hall JR, Petersen M, Yaffe K, Kind AJ, O'Bryant SE. Evaluation of Neighborhood-Level Disadvantage and Cognition in Mexican American and Non-Hispanic White Adults 50 Years and Older in the US. Jama Network Open. 6: e2325325. PMID 37647071 DOI: 10.1001/jamanetworkopen.2023.25325  0.264
2018 Vintimilla RM, Large SE, Gamboa A, Rohlfing GD, O'Jile JR, Hall JR, O'Bryant SE, Johnson LA. The Link between Potassium and Mild Cognitive Impairment in Mexican-Americans. Dementia and Geriatric Cognitive Disorders Extra. 8: 151-157. PMID 29805381 DOI: 10.1159/000488483  0.264
2012 Huebinger RM, Xiao G, Wilhelmsen KC, Diaz-Arrastia R, Zhang F, O'Bryant SE, Barber RC. Comparison of protein concentrations in serum versus plasma from Alzheimer’s patients Advances in Alzheimer's Disease. 1: 51-58. DOI: 10.1016/J.Jalz.2012.05.767  0.264
2011 Hall JR, Vo HT, Johnson LA, Barber RC, O'Bryant SE. The Link between Cognitive Measures and ADLs and IADL Functioning in Mild Alzheimer's: What Has Gender Got to Do with It? International Journal of Alzheimer's Disease. 2011: 276734. PMID 21660245 DOI: 10.4061/2011/276734  0.264
2010 Diaz-Arrastia R, Xiao G, Reisch J, Barber R, Doody R, Fairchild T, Adams P, O'Bryant S. A serum protein-based diagnostic algorithm for Alzheimer's disease Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.408  0.263
2006 O'Bryant S, Zhang F, Lee JH, Krinsky-McHale SJ, Pang D, Zigman WB, Silverman W, Schupf N. F5-01-01: PROTEOMIC BIOMARKERS FOR DETECTING AND PREDICTING AD RISK AMONG ADULTS WITH DOWN SYNDROME Alzheimer's & Dementia. 14: P1624-P1625. DOI: 10.1016/J.Jalz.2018.06.2968  0.263
2010 Barber R, Xiao G, O'Bryant S, Saunders J, Reisch J, Doody R, Fairchild T, Adams P, Ballantyne C, Diaz-Arrastia R. An inflammatory endophenotype of Alzheimer's disease Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.1767  0.262
2016 Hall JR, Wiechmann A, Edwards M, Johnson LA, O'Bryant SE. IL-7 and Depression: The importance of gender and blood fraction. Behavioural Brain Research. PMID 27555535 DOI: 10.1016/J.Jalz.2013.05.449  0.262
2017 O'Bryant SE, Edwards M, Johnson L, Hall J, Gamboa A, O'jile J. Texas Mexican American adult normative studies: Normative data for commonly used clinical neuropsychological measures for English- and Spanish-speakers. Developmental Neuropsychology. 1-26. PMID 29190120 DOI: 10.1080/87565641.2017.1401628  0.262
2017 O'Bryant SE, Edwards M, Johnson L, Hall J, Gamboa A, O'jile J. Texas Mexican American adult normative studies: Normative data for commonly used clinical neuropsychological measures for English- and Spanish-speakers. Developmental Neuropsychology. 1-26. PMID 29190120 DOI: 10.1080/87565641.2017.1401628  0.262
2014 Barber RC, Phillips NR, Mitchel JS, Huebinger RM, Koenig JL, Shewale SJ, Roby RK, Tilson JL, Diaz-Arrastia R, O'Bryant SE, Wilhelmsen KC. Genome-Wide Association Scan Of Alzheimer'S Disease Endophenotypes Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.05.272  0.262
2011 Doody R, Chan W, Barber R, Ballantyne C, Pavlik V, O'Bryant S, Darby E, Diaz-Arrastia R, Fairchild T, Royall D, Adams P. Inflammatory biomarkers in the Texas Alzheimer's Research and Care Consortium (TARCC) Cohort Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.922  0.262
2020 Petersen ME, Rafii MS, Zhang F, Hall J, Julovich D, Ances BM, Schupf N, Krinsky-McHale SJ, Mapstone M, Silverman W, Lott I, Klunk W, Head E, Christian B, Foroud T, et al. Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer's Disease Dementia and Mild Cognitive Impairment in Adults with Down Syndrome. Journal of Alzheimer's Disease : Jad. PMID 33337378 DOI: 10.3233/JAD-201167  0.261
2013 O'Bryant S. F4-01-02: Standards for Alzheimer's Disease Research in Blood Biomarkers (STAR-B) Alzheimer's & Dementia. 9: P675-P676. DOI: 10.1016/J.Jalz.2013.04.325  0.26
2014 O'Bryant S, Edwards M, Hynan L, Suen E, Smith J, Huebinger R, Cullum M, Lacritz L, Reisch J, Rosenberg RN. P3-086: APOE4 GENOTYPE IMPACTS ACCURACY OF BLOOD ALGORITHM FOR DISTINGUISHING MCI FROM AD Alzheimer's & Dementia. 10: P659-P660. DOI: 10.1016/J.Jalz.2014.05.1174  0.259
2019 Britton GB, O'Bryant SE, Johnson LA, Hall JR, Villarreal AE, Oviedo DC, Lao ARP, Carreira MB, For The Panama Aging Research Initiative SG. Inflammatory biomarkers, depressive symptoms and falls among the elderly in Panama. Current Aging Science. PMID 30767759 DOI: 10.2174/1874609812666190215125104  0.259
2019 O'Bryant SE, Edwards M, Zhang F, Johnson LA, Hall J, Kuras Y, Scherzer CR. Potential two-step proteomic signature for Parkinson's disease: Pilot analysis in the Harvard Biomarkers Study. Alzheimer's & Dementia (Amsterdam, Netherlands). 11: 374-382. PMID 31080873 DOI: 10.1016/J.Dadm.2019.03.001  0.258
2008 O'Bryant SE, Waring SC, Cullum CM, Hall J, Lacritz L, Massman PJ, Lupo PJ, Reisch JS, Doody R. Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer's research consortium study. Archives of Neurology. 65: 1091-5. PMID 18695059 DOI: 10.1001/Archneur.65.8.1091  0.256
2007 O'Bryant SE, Humphreys JD, Schiffer RB, Sutker PB. Presentation of Mexican Americans to a memory disorder clinic Journal of Psychopathology and Behavioral Assessment. 29: 137-140. DOI: 10.1007/s10862-006-9042-9  0.254
2010 Wiechmann AR, Hall JR, O'bryant S. The four-point scoring system for the Clock Drawing Test does not differentiate between Alzheimer's disease and vascular dementia Psychological Reports. 106: 941-948. PMID 20712183 DOI: 10.2466/pr0.106.3.941-948  0.254
2021 Hall JR, Johnson LA, Zhang F, Petersen M, Toga AW, Shi Y, Mason D, Rissman RA, Yaffe K, O'Bryant SE. Using Fractional Anisotropy Imaging to Detect Mild Cognitive Impairment and Alzheimer's Disease among Mexican Americans and Non-Hispanic Whites: A HABLE Study. Dementia and Geriatric Cognitive Disorders. 1-8. PMID 34569492 DOI: 10.1159/000518102  0.254
2023 Xiao C, Pappas I, Aksman LM, O'Bryant SE, Toga AW. Comparison of genetic and health risk factors for mild cognitive impairment and Alzheimer's disease between Hispanic and non-Hispanic white participants. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37104247 DOI: 10.1002/alz.13110  0.253
2021 Hall JR, Petersen M, Johnson L, O'Bryant SE. Plasma Total Tau and Neurobehavioral Symptoms of Cognitive Decline in Cognitively Normal Older Adults. Frontiers in Psychology. 12: 774049. PMID 34803857 DOI: 10.3389/fpsyg.2021.774049  0.253
2020 Torres S, Alexander A, O'Bryant S, Medina LD. Cognition and the Predictive Utility of Three Risk Scores in an Ethnically Diverse Sample. Journal of Alzheimer's Disease : Jad. PMID 32390625 DOI: 10.3233/Jad-191284  0.251
2006 Johnson LA, Munoz HI, Large S, Vintimilla R, O'Jile J, Hall JR, O'Bryant S. P2-484: THE IMPACT OF VASCULAR RISK AND DEPRESSION ON EXECUTIVE FUNCTION AMONG MEXICAN AMERICAN WOMEN Alzheimer's & Dementia. 14: P914-P915. DOI: 10.1016/J.Jalz.2018.06.1177  0.251
2018 Hall JR, Wiechmann A, Johnson LA, Edwards M, O'Bryant SE. Characteristics of Cognitively Normal Mexican-Americans with Cognitive Complaints. Journal of Alzheimer's Disease : Jad. 61: 1485-1492. PMID 29376872 DOI: 10.3233/JAD-170836  0.251
2020 Deiner S, Baxter MG, Mincer JS, Sano M, Hall J, Mohammed I, O'Bryant S, Zetterberg H, Blennow K, Eckenhoff R. Human plasma biomarker responses to inhalational general anaesthesia without surgery. British Journal of Anaesthesia. PMID 32536445 DOI: 10.1016/J.Bja.2020.04.085  0.251
2006 Vintimilla R, Hall JR, Johnson LA, O'Bryant S. P3-330: THE RELATIONSHIP OF HYPERTENSION AND RELATED CARDIOVASCULAR RISK FACTORS TO EXECUTIVE FUNCTIONING IN MEXICAN AMERICANS Alzheimer's & Dementia. 14: P1207-P1207. DOI: 10.1016/J.Jalz.2018.06.1691  0.25
2022 Gonzales MM, Wang CP, Short MI, Parent DM, Kautz T, MacCarthy D, Satizabal CL, González DA, Royall DR, Zare H, O'Bryant S, Maestre GE, Tracy RP, Seshadri S. Blood biomarkers for cognitive decline and clinical progression in a Mexican American cohort. Alzheimer's & Dementia (Amsterdam, Netherlands). 14: e12298. PMID 35356487 DOI: 10.1002/dad2.12298  0.25
2021 O'Bryant SE, Zhang F, Petersen M, Hall JR, Johnson LA, Yaffe K, Mason D, Braskie M, Barber RA, Rissman RA, Mapstone M, Mielke MM, Toga AW. A blood screening tool for detecting mild cognitive impairment and Alzheimer's disease among community-dwelling Mexican Americans and non-Hispanic Whites: A method for increasing representation of diverse populations in clinical research. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34057802 DOI: 10.1002/alz.12382  0.25
2021 Vintimilla R, Hall J, King K, Braskie MN, Johnson L, Yaffe K, Toga AW, O'Bryant S. MRI biomarkers of small vessel disease and cognition: A cross-sectional study of a cognitively normal Mexican American cohort. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12236. PMID 34692977 DOI: 10.1002/dad2.12236  0.249
2022 O'Bryant SE, Petersen M, Hall J, Johnson LA, Barber R, Phillips N, Braskie MN, Yaffe K, Rissman R, Toga A. Characterization of Mild Cognitive Impairment and Dementia among Community-Dwelling Mexican Americans and Non-Hispanic Whites. Journal of Alzheimer's Disease : Jad. PMID 36189588 DOI: 10.3233/JAD-220300  0.248
2017 Hall JR, Balldin VH, Gamboa A, Edwards ML, Johnson LA, O'Bryant SE. Texas Mexican American adult normative studies: Normative data for the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). Developmental Neuropsychology. 1-9. PMID 29185823 DOI: 10.1080/87565641.2017.1401629  0.248
2020 Petersen M, Hall J, Parsons T, Johnson L, O'Bryant S. Combining Select Blood-Based Biomarkers with Neuropsychological Assessment to Detect Mild Cognitive Impairment among Mexican Americans. Journal of Alzheimer's Disease : Jad. PMID 32310167 DOI: 10.3233/Jad-191264  0.247
2012 O'Bryant S, Xiao G, Barber R, Edwards M, Hall J. P2-064: Serum-based biomarker algorithms of neuropsychological functioning Alzheimer's & Dementia. 8: P285-P285. DOI: 10.1016/J.Jalz.2012.05.768  0.247
2013 Johnson LA, Phillips JA, Mauer C, Edwards M, Balldin VH, Hall JR, Barber R, Conger TL, Ho EJ, O'Bryant SE. The impact of GPX1 on the association of groundwater selenium and depression: a Project FRONTIER study. Bmc Psychiatry. 13: 7. PMID 23289525 DOI: 10.1186/1471-244X-13-7  0.247
2022 Moni F, Petersen ME, Zhang F, Lao PJ, Zimmerman ME, Gu Y, Gutierrez J, Rizvi B, Laing KK, Igwe KC, Sathishkumar M, Keator D, Andrews H, Krinsky-McHale S, Head E, et al. Probing the proteome to explore potential correlates of increased Alzheimer's-related cerebrovascular disease in adults with Down syndrome. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35212182 DOI: 10.1002/alz.12627  0.246
2021 Hall JR, Johnson LA, Peterson M, Julovich D, Como T, O'Bryant SE. Relationship of Neurofilament light (NfL) and Cognitive Performance in a Sample of Mexican Americans with Normal Cognition, Mild Cognitive Impairment and Dementia. Current Alzheimer Research. PMID 33605860 DOI: 10.2174/1567205018666210219105949  0.245
2020 O'Bryant SE, Zhang F, Silverman W, Lee JH, Krinsky-McHale SJ, Pang D, Hall J, Schupf N. Proteomic profiles of incident mild cognitive impairment and Alzheimer's disease among adults with Down syndrome. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12033. PMID 32490140 DOI: 10.1002/dad2.12033  0.244
2022 O'Bryant SE, Barber RC, Philips N, Johnson LA, Hall JR, Subasinghe K, Petersen M, Toga AW, Yaffe K, Rissman RA. The Link between APOE4 Presence and Neuropsychological Test Performance among Mexican Americans and Non-Hispanic Whites of the Multiethnic Health & Aging Brain Study - Health Disparities Cohort. Dementia and Geriatric Cognitive Disorders. 1-6. PMID 35226898 DOI: 10.1159/000521898  0.24
2022 O'Bryant SE, Petersen M, Hall J, Johnson LA. Depression is differentially related to cognitive and biomarker outcomes among Mexican Americans. Frontiers in Psychiatry. 13: 901403. PMID 36081458 DOI: 10.3389/fpsyt.2022.901403  0.239
2014 O'Bryant S, Rissman RA, Lyketsos C. O4-11-03: A PROINFLAMMATORY ENDOPHENOTYPE PREDICTS TREATMENT RESPONSE IN A MULTICENTER TRIAL OF NSAIDS IN AD Alzheimer's & Dementia. 10: P273-P274. DOI: 10.1016/J.Jalz.2014.04.447  0.236
2010 Huebinger RM, Wilhelmsen K, Diaz-Arrastia R, Chasse S, O'Bryant SE, Doody R, Fairchild T, Adams P, Reisch J, Barber RC. Association of genetic variation in the electron transport chain and Alzheimer's disease Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.623  0.236
2004 O'Bryant SE, O'Jile JR. Attenuating demographic influences on verbal fluency and animal naming in a psychiatric sample. Applied Neuropsychology. 11: 210-4. PMID 15673493 DOI: 10.1207/s15324826an1104_6  0.234
2015 O'Bryant S. S5-01-02: Blood biomarker assays Alzheimer's & Dementia. 11: P302-P302. DOI: 10.1016/J.Jalz.2015.07.420  0.233
2013 Johnson LA, Hall JR, O'Bryant SE. A depressive endophenotype of mild cognitive impairment and Alzheimer's disease. Plos One. 8: e68848. PMID 23874786 DOI: 10.1371/journal.pone.0068848  0.232
2022 Vintimilla R, Mathew E, Hall J, Johnson L, O'Bryant S. Subjective cognitive complaints and cardiovascular risk factors in older Mexican Americans: A cross-sectional study. Cerebral Circulation - Cognition and Behavior. 3: 100126. PMID 36324397 DOI: 10.1016/j.cccb.2022.100126  0.231
2020 Vintimilla R, Balasubramanian K, Hall J, Johnson L, O'Bryant S. Cardiovascular Risk Factors, Cognitive Dysfunction, and Mild Cognitive Impairment. Dementia and Geriatric Cognitive Disorders Extra. 10: 154-162. PMID 33442392 DOI: 10.1159/000511103  0.231
2015 Edwards M, Balldin VH, Hall J, O'Bryant S. Molecular markers of neuropsychological functioning and Alzheimer's disease Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. 1: 61-66. DOI: 10.1016/j.dadm.2014.11.001  0.231
2019 Johnson LA, Large SE, Izurieta Munoz H, Hall JR, O'Bryant SE. Vascular Depression and Cognition in Mexican Americans. Dementia and Geriatric Cognitive Disorders. 47: 68-78. PMID 30861514 DOI: 10.1159/000494272  0.229
2010 Hobson VL, Hall JR, Humphreys-Clark JD, Schrimsher GW, O'Bryant SE. Identifying functional impairment with scores from the repeatable battery for the assessment of neuropsychological status (RBANS). International Journal of Geriatric Psychiatry. 25: 525-30. PMID 19862695 DOI: 10.1002/gps.2382  0.229
2011 Gong G, Hargrave KA, Hobson V, Spallholz J, Boylan M, Lefforge D, O'Bryant SE. Low-level groundwater arsenic exposure impacts cognition: a project FRONTIER study. Journal of Environmental Health. 74: 16-22. PMID 21949980  0.228
2006 O'Bryant SE, Marcus DA, Rains JC, Penzien DB. The neuropsychology of recurrent headache. Headache. 46: 1364-76. PMID 17040333 DOI: 10.1111/j.1526-4610.2006.00579.x  0.227
2023 Zhang F, Petersen M, Johnson L, Hall J, O'Bryant SE. Comorbidities Incorporated to Improve Prediction for Prevalent Mild Cognitive Impairment and Alzheimer's Disease in the HABS-HD Study. Journal of Alzheimer's Disease : Jad. PMID 38007662 DOI: 10.3233/JAD-230755  0.226
2023 Hampel H, Hu Y, Cummings J, Mattke S, Iwatsubo T, Nakamura A, Vellas B, O'Bryant S, Shaw LM, Cho M, Batrla R, Vergallo A, Blennow K, Dage J, Schindler SE. Blood-based biomarkers for Alzheimer's disease: Current state and future use in a transformed global healthcare landscape. Neuron. PMID 37295421 DOI: 10.1016/j.neuron.2023.05.017  0.225
2022 O'Bryant SE, Petersen M, Hall J, Large S, Johnson LA. Plasma Biomarkers of Alzheimer's Disease Are Associated with Physical Functioning Outcomes Among Cognitively Normal Adults in the Multi-Ethnic HABS-HD Cohort. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. PMID 35980599 DOI: 10.1093/gerona/glac169  0.225
2023 Clark AL, Thomas KR, Ortega N, Haley AP, Duarte A, O'Bryant S. Empirically derived psychosocial-behavioral phenotypes in Black/African American and Hispanic/Latino older adults enrolled in HABS-HD: Associations with AD biomarkers and cognitive outcomes. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37990803 DOI: 10.1002/alz.13544  0.224
2012 Cicero A, Oberoi P, O'Bryant S, Barber R, Dunty J, Stewart D, Umek R, Eason P. P1-323: The impact of assay format on sensitivity and matrix tolerance for plasma beta-amyloid peptide (Aβ-40 and Aβ-42) measurements Alzheimer's & Dementia. 8: P218-P218. DOI: 10.1016/J.Jalz.2012.05.2009  0.224
2012 Ferrari R, Moreno JH, Minhajuddin AT, O'Bryant SE, Reisch JS, Barber RC, Momeni P. Implication of common and disease specific variants in CLU, CR1, and PICALM. Neurobiology of Aging. 33: 1846.e7-18. PMID 22402018 DOI: 10.1016/J.Neurobiolaging.2012.01.110  0.223
2023 Jiang X, O'Bryant SE, Johnson LA, Rissman RA, Yaffe K. Association of cardiovascular risk factors and blood biomarkers with cognition: The HABS-HD study. Alzheimer's & Dementia (Amsterdam, Netherlands). 15: e12394. PMID 36911361 DOI: 10.1002/dad2.12394  0.221
2016 Johnson LA, Weiser B, Gamboa A, Vintimilla R, Edwards M, Wong L, Large S, Hall JR, O'Bryant S. P3-176: Biomarkers of a Depressive Endophenotype Alzheimer's & Dementia. 12: P888-P888. DOI: 10.1016/J.Jalz.2016.06.1836  0.221
2019 Hall JR, Wiechmann AR, Johnson LA, Edwards ML, O'Bryant SE. Levels of α-2 Macroglobulin in cognitively normal Mexican- Americans with Subjective Cognitive Decline: A HABLE Study. Current Neurobiology. 10: 22-25. PMID 31061568  0.218
2017 Pedrini S, Gupta VB, Hone E, Doecke JD, O'Bryant S, James I, Bush AI, Rowe CC, Villemagne VLL, Ames D, Masters CL, Martins RN. IL-10 AND IL-12/23P40 ARE JOINTLY ASSOCIATED AS PREDICTORS OF Aβ-AMYLOID LOAD IN A BROADER BLOOD-BASED BIOMARKER PANEL Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.2002  0.217
2022 Quiroz YT, Solis M, Aranda MP, Arbaje AI, Arroyo-Miranda M, Cabrera LY, Carrasquillo MM, Corrada MM, Crivelli L, Diminich ED, Dorsman KA, Gonzales M, González HM, Gonzalez-Seda AL, Grinberg LT, et al. Addressing the disparities in dementia risk, early detection and care in Latino populations: Highlights from the second Latinos & Alzheimer's Symposium. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35199931 DOI: 10.1002/alz.12589  0.217
2022 Yassine HN, Samieri C, Livingston G, Glass K, Wagner M, Tangney C, Plassman BL, Ikram MA, Voigt RM, Gu Y, O'Bryant S, Minihane AM, Craft S, Fink HA, Judd S, et al. Nutrition state of science and dementia prevention: recommendations of the Nutrition for Dementia Prevention Working Group. The Lancet. Healthy Longevity. 3: e501-e512. PMID 35821792 DOI: 10.1016/s2666-7568(22)00120-9  0.217
2013 O'Bryant SE, Xiao G, Edwards M, Devous M, Gupta VB, Martins R, Zhang F, Barber R. Biomarkers of Alzheimer's disease among Mexican Americans. Journal of Alzheimer's Disease : Jad. 34: 841-9. PMID 23313927 DOI: 10.3233/Jad-122074  0.216
2005 O'Jile JR, Schrimsher GW, O'Bryant SE. The California Verbal Learning Test-Children's Version: relation to factor indices of the Wechsler Intelligence Scale for Children-Third Edition. Journal of Clinical and Experimental Neuropsychology. 27: 815-22. PMID 16183615 DOI: 10.1080/13803390490918598  0.213
2019 Pathak GA, Silzer TK, Sun J, Zhou Z, Daniel AA, Johnson L, O'Bryant S, Phillips NR, Barber RC. Genome-Wide Methylation of Mild Cognitive Impairment in Mexican Americans Highlights Genes Involved in Synaptic Transport, Alzheimer's Disease-Precursor Phenotypes, and Metabolic Morbidities. Journal of Alzheimer's Disease : Jad. PMID 31640099 DOI: 10.3233/JAD-190634  0.211
2012 Hall JR, Johnson LA, Barber RC, Vo HT, Winter AS, O'Bryant SE. Biomarkers of basic activities of daily living in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 31: 429-37. PMID 22571981 DOI: 10.3233/JAD-2012-111481  0.21
2018 Baldacci F, Lista S, O'Bryant SE, Ceravolo R, Toschi N, Hampel H. Blood-Based Biomarker Screening with Agnostic Biological Definitions for an Accurate Diagnosis Within the Dimensional Spectrum of Neurodegenerative Diseases. Methods in Molecular Biology (Clifton, N.J.). 1750: 139-155. PMID 29512070 DOI: 10.1007/978-1-4939-7704-8_9  0.207
2023 Stern AM, Van Pelt KL, Liu L, Anderson AK, Ostaszewski B, Mapstone M, O'Bryant S, Petersen ME, Christian BT, Handen BL, Selkoe DJ, Schmitt F, Head E. Plasma NT1-tau and Aβ correlate with age and cognitive function in two large Down syndrome cohorts. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37438872 DOI: 10.1002/alz.13382  0.207
2013 O'Bryant SE, Johnson L, Reisch J, Edwards M, Hall J, Barber R, Devous MD, Royall D, Singh M. Risk factors for mild cognitive impairment among Mexican Americans. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 622-631.e1. PMID 23643456 DOI: 10.1016/J.Jalz.2012.12.007  0.207
2017 Lewczuk P, Riederer P, O'Bryant SE, Verbeek MM, Dubois B, Visser PJ, Jellinger KA, Engelborghs S, Ramirez A, Parnetti L, Jack CR, Teunissen CE, Hampel H, Lleó A, Jessen F, et al. Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-85. PMID 29076399 DOI: 10.1080/15622975.2017.1375556  0.205
2015 Edwards M, Balldin VH, Hall J, O'Bryant S. Molecular markers of neuropsychological functioning and Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 1: 61-6. PMID 27239492 DOI: 10.1016/j.dadm.2014.11.001  0.204
2023 Stern AM, Van Pelt KL, Liu L, Anderson AK, Ostaszewski B, Mapstone M, O'Bryant S, Petersen ME, Christian BT, Handen BL, Selkoe DJ, Schmitt F, Head E. Plasma NT1-tau and Aβ correlate with age and cognitive function in two large Down syndrome cohorts. Medrxiv : the Preprint Server For Health Sciences. PMID 36945447 DOI: 10.1101/2023.03.10.23287109  0.203
2014 Edwards M, Johnson L, Mauer C, Barber R, Hall J, O'Bryant S. Regional specific groundwater arsenic levels and neuropsychological functioning: a cross-sectional study. International Journal of Environmental Health Research. 24: 546-57. PMID 24506178 DOI: 10.1080/09603123.2014.883591  0.202
2005 O'Bryant SE, Schrimsher GW, O'Jile JR. Discrepancies between self-reported years of education and estimated reading level: potential implications for neuropsychologists. Applied Neuropsychology. 12: 5-11. PMID 15788217 DOI: 10.1207/s15324826an1201_2  0.201
2011 Williams M, Meisel M, Williams J, O'Bryant S, Braddock E, Ramirez V, Hudson C, Dentino A. P2-413: Social marketing for minority recruitment in rural and urban settings Alzheimer's & Dementia. 7: S443-S444. DOI: 10.1016/J.Jalz.2011.05.1286  0.2
2015 Johnson LA, Gamboa A, Vintimilla R, Cheatwood AJ, Grant A, Trivedi A, Edwards M, Hall JR, O'Bryant SE. Comorbid Depression and Diabetes as a Risk for Mild Cognitive Impairment and Alzheimer's Disease in Elderly Mexican Americans. Journal of Alzheimer's Disease : Jad. 47: 129-36. PMID 26402761 DOI: 10.3233/JAD-142907  0.199
2017 Pedrini S, Gupta VB, Hone E, Doecke J, O'Bryant S, James I, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Martins RN. A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohort. Scientific Reports. 7: 14057. PMID 29070909 DOI: 10.1038/S41598-017-14020-9  0.196
2015 Szerlip HM, Edwards ML, Williams BJ, Johnson LA, Vintimilla RM, O'Bryant SE. Association Between Cognitive Impairment and Chronic Kidney Disease in Mexican Americans. Journal of the American Geriatrics Society. PMID 26456700 DOI: 10.1111/jgs.13665  0.194
2022 Mozdbar S, Alber J, Aryal S, Johnson L, Moroz A, Rashik M, Mostafavi A, O'Bryant S. Cognitive dysfunction and the 25-item National Eye Institute Visual Function Questionnaire. Alzheimer's & Dementia (Amsterdam, Netherlands). 14: e12378. PMID 36407937 DOI: 10.1002/dad2.12378  0.192
2014 Henriksen K, O'Bryant SE, Hampel H, Trojanowski JQ, Montine TJ, Jeromin A, Blennow K, Lönneborg A, Wyss-Coray T, Soares H, Bazenet C, Sjögren M, Hu W, Lovestone S, Karsdal MA, et al. The future of blood-based biomarkers for Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 115-31. PMID 23850333 DOI: 10.1016/J.Jalz.2013.01.013  0.191
2015 Hall JR, Wiechmann AR, Cunningham RL, Johnson LA, Edwards M, Barber RC, Singh M, Winter S, O'Bryant SE. Total testosterone and neuropsychiatric symptoms in elderly men with Alzheimer's disease. Alzheimer's Research & Therapy. 7: 24. PMID 25937840 DOI: 10.1186/S13195-015-0107-4  0.189
2019 Silzer T, Barber R, Sun J, Pathak G, Johnson L, O'Bryant S, Phillips N. Circulating mitochondrial DNA: New indices of type 2 diabetes-related cognitive impairment in Mexican Americans. Plos One. 14: e0213527. PMID 30861027 DOI: 10.1371/journal.pone.0213527  0.186
2022 Mozdbar S, Petersen M, Zhang F, Johnson L, Tolman A, Nyalakonda R, Gutierrez A, O'Bryant S. Application of Structural Retinal Biomarkers to Detect Cognitive Impairment in a Primary Care Setting. Journal of Alzheimer's Disease Reports. 6: 749-755. PMID 36721487 DOI: 10.3233/ADR-220070  0.185
2022 Hall JR, Petersen M, Johnson L, O'Bryant SE. Characterizing Plasma Biomarkers of Alzheimer's in a Diverse Community-Based Cohort: A Cross-Sectional Study of the HAB-HD Cohort. Frontiers in Neurology. 13: 871947. PMID 36062019 DOI: 10.3389/fneur.2022.871947  0.185
2022 O'Bryant SE, Petersen M, Hall J, Johnson L. APOEε4 Genotype Is Related to Brain Amyloid Among Mexican Americans in the HABS-HD Study. Frontiers in Neurology. 13: 834685. PMID 35785339 DOI: 10.3389/fneur.2022.834685  0.184
2023 Edwards NC, Lao PJ, Alshikho MJ, Ericsson OM, Rizvi B, Petersen ME, O'Bryant S, Flores-Aguilar L, Simoes S, Mapstone M, Tudorascu DL, Janelidze S, Hansson O, Handen BL, Christian BT, et al. Cerebrovascular disease drives Alzheimer plasma biomarker concentrations in adults with Down syndrome. Medrxiv : the Preprint Server For Health Sciences. PMID 38076904 DOI: 10.1101/2023.11.28.23298693  0.184
2020 Rafii MS, Ances BM, Schupf N, Krinsky-McHale SJ, Mapstone M, Silverman W, Lott I, Klunk W, Head E, Christian B, Lai F, Rosas HD, Zaman S, Petersen ME, Strydom A, et al. The AT(N) framework for Alzheimer's disease in adults with Down syndrome. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12062. PMID 33134477 DOI: 10.1002/dad2.12062  0.184
2022 O'Bryant SE, Zhang F, Petersen M, Hall JR, Johnson LA, Yaffe K, Braskie M, Vig R, Toga AW, Rissman RA. Proteomic Profiles of Neurodegeneration Among Mexican Americans and Non-Hispanic Whites in the HABS-HD Study. Journal of Alzheimer's Disease : Jad. PMID 35180110 DOI: 10.3233/JAD-210543  0.183
2023 Rajabli F, Benchek P, Tosto G, Kushch N, Sha J, Bazemore K, Zhu C, Lee WP, Haut J, Hamilton-Nelson KL, Wheeler NR, Zhao Y, Farrell JJ, Grunin MA, Leung YY, et al. Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies and nominates ancestry-specific loci , , and as novel risk loci for Alzheimer's disease: the Alzheimer's Disease Genetics Consortium. Medrxiv : the Preprint Server For Health Sciences. PMID 37461624 DOI: 10.1101/2023.07.06.23292311  0.182
2021 Rasu RS, Shrestha N, Karpes Matusevich AR, Zalmai R, Large S, Johnson L, O'Bryant SE. Polypharmacy and Cognition Function Among Rural Adults. Journal of Alzheimer's Disease : Jad. PMID 34057144 DOI: 10.3233/JAD-200951  0.181
2005 O'Jile JR, Schrimsher GW, O'Bryant SE. The relation of self-report of mood and anxiety to CVLT-C, CVLT, and CVLT-2 in a psychiatric sample. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 20: 547-53. PMID 15896567 DOI: 10.1016/j.acn.2004.12.001  0.18
2017 Lista S, Zetterberg H, O'Bryant SE, Blennow K, Hampel H. Evolving Relevance of Neuroproteomics in Alzheimer's Disease. Methods in Molecular Biology (Clifton, N.J.). 1598: 101-115. PMID 28508359 DOI: 10.1007/978-1-4939-6952-4_5  0.175
2021 O'Bryant SE, Johnson LA, Barber RC, Braskie MN, Christian B, Hall JR, Hazra N, King K, Kothapalli D, Large S, Mason D, Matsiyevskiy E, McColl R, Nandy R, Palmer R, et al. The Health & Aging Brain among Latino Elders (HABLE) study methods and participant characteristics. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12202. PMID 34189247 DOI: 10.1002/dad2.12202  0.173
2023 Housini M, Zhou Z, Gutierrez J, Rao S, Jomaa R, Subasinghe K, Reid DM, Silzer T, Phillips N, O'Bryant S, Barber RC. Top Alzheimer's disease risk allele frequencies differ in HABS-HD Mexican- versus Non-Hispanic White Americans. Alzheimer's & Dementia (Amsterdam, Netherlands). 15: e12518. PMID 38155914 DOI: 10.1002/dad2.12518  0.17
2007 O'Bryant SE, Finlay CG, O'Jile JR. TOMM performances and self-reported symptoms of depression and anxiety Journal of Psychopathology and Behavioral Assessment. 29: 111-114. DOI: 10.1007/s10862-006-9034-9  0.17
2018 Molinuevo JL, Ayton S, Batrla R, Bednar MM, Bittner T, Cummings J, Fagan AM, Hampel H, Mielke MM, Mikulskis A, O'Bryant S, Scheltens P, Sevigny J, Shaw LM, Soares HD, et al. Current state of Alzheimer's fluid biomarkers. Acta Neuropathologica. 136: 821-853. PMID 30488277 DOI: 10.1007/S00401-018-1932-X  0.168
2022 O'Bryant SE, Petersen M, Hall J, Johnson L. Metabolic Factors Are Related to Brain Amyloid Among Mexican Americans: A HABS-HD Study. Journal of Alzheimer's Disease : Jad. PMID 35253763 DOI: 10.3233/JAD-215620  0.164
2022 Zhang F, Petersen M, Johnson L, Hall J, O'Bryant SE. Hyperparameter Tuning with High Performance Computing Machine Learning for Imbalanced Alzheimer's Disease Data. Applied Sciences (Basel, Switzerland). 12. PMID 36381541 DOI: 10.3390/app12136670  0.164
2019 Winston CN, Romero HK, Ellisman M, Nauss S, Julovich DA, Conger T, Hall JR, Campana W, O'Bryant SE, Nievergelt CM, Baker DG, Risbrough VB, Rissman RA. Assessing Neuronal and Astrocyte Derived Exosomes From Individuals With Mild Traumatic Brain Injury for Markers of Neurodegeneration and Cytotoxic Activity. Frontiers in Neuroscience. 13: 1005. PMID 31680797 DOI: 10.3389/fnins.2019.01005  0.163
2008 Schrimsher GW, O'Bryant SE, O'Jile JR, Sutker PB. Comparison of tetradic WAIS-III short forms in predicting full scale IQ scores in neuropsychiatric clinic settings Journal of Psychopathology and Behavioral Assessment. 30: 235-240. DOI: 10.1007/s10862-007-9066-9  0.163
2009 Mendoza JE, Apostolos GT, Humphreys JD, Hanna-Pladdy B, O'Bryant SE. Coin rotation task (CRT): a new test of motor dexterity. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 24: 287-92. PMID 19592523 DOI: 10.1093/Arclin/Acp030  0.161
2014 Hall JR, Wiechmann AR, Johnson LA, Edwards M, Barber RC, Cunningham R, Singh M, O'Bryant SE. The impact of APOE status on relationship of biomarkers of vascular risk and systemic inflammation to neuropsychiatric symptoms in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 40: 887-96. PMID 24577461 DOI: 10.3233/Jad-131724  0.16
2010 Gong G, OʼBryant SE. The arsenic exposure hypothesis for Alzheimer disease. Alzheimer Disease and Associated Disorders. 24: 311-6. PMID 20473132 DOI: 10.1097/WAD.0b013e3181d71bc7  0.158
2016 O'Bryant SE, Edwards M, Johnson L, Hall J, Villarreal AE, Britton GB, Quiceno M, Cullum CM, Graff-Radford NR. A blood screening test for Alzheimer's disease Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. 3: 83-90. DOI: 10.1016/j.dadm.2016.06.004  0.157
2013 Ferrari R, Dawoodi S, Raju M, Thumma A, Hynan LS, Maasumi SH, Reisch JS, O'Bryant S, Jenkins M, Barber R, Momeni P. Androgen receptor gene and sex-specific Alzheimer's disease Neurobiology of Aging. 34: e19-e20. PMID 23545426 DOI: 10.1016/j.neurobiolaging.2013.02.017  0.157
2010 Hall JR, O'Bryant SE, Barber R, Massman P. P3-141: The relation between level of depression and neuropsychological functioning in patients with Alzheimer's disease Alzheimer's & Dementia. 6: S491-S491. DOI: 10.1016/J.Jalz.2010.05.1638  0.157
2023 Vintimilla R, Seyedahmadi A, Hall J, Johnson L, O'Bryant S. Association of Area Deprivation Index and hypertension, diabetes, dyslipidemia, and Obesity: A Cross-Sectional Study of the HABS-HD Cohort. Gerontology & Geriatric Medicine. 9: 23337214231182240. PMID 37361029 DOI: 10.1177/23337214231182240  0.154
2022 O'Bryant SE, Petersen M, Hall J, Johnson LA. Medical comorbidities and ethnicity impact plasma Alzheimer's disease biomarkers: Important considerations for clinical trials and practice. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35235702 DOI: 10.1002/alz.12647  0.154
2011 O'Bryant SE, Xiao G, Barber R, Huebinger R, Wilhelmsen K, Edwards M, Graff-Radford N, Doody R, Diaz-Arrastia R. A blood-based screening tool for Alzheimer's disease that spans serum and plasma: findings from TARC and ADNI. Plos One. 6: e28092. PMID 22163278 DOI: 10.1371/Journal.Pone.0028092  0.152
2014 Hall JR, Wiechmann AR, Johnson LA, Edwards M, Barber RC, Cunningham R, Singh M, O'Bryant SE. Total cholesterol and neuropsychiatric symptoms in Alzheimer's disease: the impact of total cholesterol level and gender. Dementia and Geriatric Cognitive Disorders. 38: 300-9. PMID 25011444 DOI: 10.1159/000361043  0.151
2011 O'Bryant SE, Falkowski J, Hobson V, Johnson L, Hall J, Schrimsher GW, Win O, Ngo B, Dentino A. Executive functioning mediates the link between other neuropsychological domains and daily functioning: a Project FRONTIER study. International Psychogeriatrics / Ipa. 23: 107-13. PMID 20637139 DOI: 10.1017/S1041610210000967  0.151
2021 Zhang F, Petersen M, Johnson L, Hall J, O'Bryant SE. Accelerating Hyperparameter Tuning in Machine Learning for Alzheimer's Disease With High Performance Computing. Frontiers in Artificial Intelligence. 4: 798962. PMID 34957393 DOI: 10.3389/frai.2021.798962  0.147
2019 Rafii MS, Donohue MC, Matthews DC, Muranevici G, Ness S, O'Bryant SE, Rissman RA. Plasma Neurofilament Light and Alzheimer's Disease Biomarkers in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI). Journal of Alzheimer's Disease : Jad. PMID 31156181 DOI: 10.3233/JAD-190322  0.146
2023 Yang Z, Wen J, Erus G, Govindarajan ST, Melhem R, Mamourian E, Cui Y, Srinivasan D, Abdulkadir A, Parmpi P, Wittfeld K, Grabe HJ, Bülow R, Frenzel S, Tosun D, et al. Five dominant dimensions of brain aging are identified via deep learning: associations with clinical, lifestyle, and genetic measures. Medrxiv : the Preprint Server For Health Sciences. PMID 38234857 DOI: 10.1101/2023.12.29.23300642  0.145
2022 Boerwinkle AH, Gordon BA, Wisch J, Flores S, Henson RL, Butt OH, McKay N, Chen CD, Benzinger TLS, Fagan AM, Handen BL, Christian BT, Head E, Mapstone M, Rafii MS, et al. Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study. The Lancet. Neurology. 22: 55-65. PMID 36517172 DOI: 10.1016/S1474-4422(22)00408-2  0.144
2021 Zhang F, Petersen M, Johnson L, Hall J, O'Bryant SE. Recursive Support Vector Machine Biomarker Selection for Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 33492292 DOI: 10.3233/JAD-201254  0.143
2021 O'Bryant S, Zhang F, Petersen M, Johnson L, Hall J, Rissman RA. A Precision Medicine Approach to Treating Alzheimer's Disease Using Rosiglitazone Therapy: A Biomarker Analysis of the REFLECT Trials. Journal of Alzheimer's Disease : Jad. PMID 33814447 DOI: 10.3233/JAD-201610  0.142
2016 O'Bryant SE. Introduction to special issue on Advances in blood-based biomarkers of Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 3: 110-2. PMID 27453933 DOI: 10.1016/j.dadm.2016.06.003  0.14
2023 O'Bryant SE, Zhang F, Johnson LA, Hall J, Petersen M, Oh ES, Lyketsos CG, Rissman RA. Precision Medicine for Preventing Alzheimer's Disease: Analysis of the ADAPT Study. Journal of Alzheimer's Disease : Jad. PMID 37718801 DOI: 10.3233/JAD-230317  0.14
2019 Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, Bellenguez C, Frizatti A, Chouraki V, Martin ER, Sleegers K, et al. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nature Genetics. 51: 414-430. PMID 30820047 DOI: 10.1038/s41588-019-0358-2  0.14
2024 DiProspero N, Sathishkumar M, Janecek J, Smith A, McMillan L, Petersen M, Tustison N, Keator DB, Doran E, Hom CL, Nguyen D, Andrews H, Krinsky-McHale S, Brickman AM, Rosas HD, et al. Neurofilament light chain concentration mediates the association between regional medial temporal lobe structure and memory in adults with Down syndrome. Alzheimer's & Dementia (Amsterdam, Netherlands). 16: e12542. PMID 38348178 DOI: 10.1002/dad2.12542  0.14
2022 King KS, Vintimilla RM, Braskie MN, Wei K, Hall JR, Borzage M, Johnson LA, Yaffe K, Toga AW, O'Bryant SE. Vascular risk profile and white matter hyperintensity volume among Mexican Americans and non-Hispanic Whites: The HABLE study. Alzheimer's & Dementia (Amsterdam, Netherlands). 14: e12263. PMID 35229016 DOI: 10.1002/dad2.12263  0.139
2016 O'Bryant SE, Lista S, Rissman RA, Edwards M, Zhang F, Hall J, Zetterberg H, Lovestone S, Gupta V, Graff-Radford N, Martins R, Jeromin A, Waring S, Oh E, Kling M, et al. Comparing biological markers of Alzheimer's disease across blood fraction and platforms: Comparing apples to oranges Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. 3: 27-34. DOI: 10.1016/j.dadm.2015.12.003  0.138
2011 Hall J, Johnson L, Barber R, O'Bryant S. P1-418: CRP and depressive symptoms in Alzheimer's disease Alzheimer's & Dementia. 7: S246-S246. DOI: 10.1016/j.jalz.2011.05.699  0.135
2022 Zhang F, Petersen M, Johnson L, Hall J, O'Bryant SE. Combination of Serum and Plasma Biomarkers Could Improve Prediction Performance for Alzheimer's Disease. Genes. 13. PMID 36292623 DOI: 10.3390/genes13101738  0.133
2021 Handen B, Clare I, Laymon C, Petersen M, Zaman S, O'Bryant S, Minhas D, Tudorascu D, Brown S, Christian B. Acute Regression in Down Syndrome. Brain Sciences. 11. PMID 34439728 DOI: 10.3390/brainsci11081109  0.132
2019 Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, Bellenguez C, Frizatti A, Chouraki V, Martin ER, Sleegers K, et al. Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nature Genetics. PMID 31417202 DOI: 10.1038/s41588-019-0495-7  0.131
2022 O'Bryant SE, Petersen M, Zhang F, Johnson L, German D, Hall J. Parkinson's Disease Blood Test for Primary Care. Journal of Alzheimer's Disease & Parkinsonism. 12. PMID 37006377  0.129
2022 Clark AL, Haley AP, Duarte A, O'Bryant S. Fatty Acid-Binding Protein 3 is a Marker of Neurodegeneration and White Matter Hyperintensity Burden in Mexican American Older Adults. Journal of Alzheimer's Disease : Jad. PMID 36093702 DOI: 10.3233/JAD-220524  0.129
2012 O'Bryant SE. Using blood markers for Alzheimer disease in clinical practice? Neurology. 79: 846-7. PMID 22855864 DOI: 10.1212/WNL.0b013e318266fd21  0.126
2021 O'Bryant SE, Petersen M, Zhang F, Johnson L, Mason D, Hall J. Analysis of a precision medicine approach to treating Parkinson's disease: Analysis of the DATATOP study. Parkinsonism & Related Disorders. 94: 15-21. PMID 34864471 DOI: 10.1016/j.parkreldis.2021.11.027  0.125
2020 Morris JK, John CS, Green ZD, Wilkins HM, Wang X, Kamat A, Swerdlow RS, Vidoni ED, Petersen ME, O'Bryant SE, Honea RA, Burns JM. Characterization of the Meal-Stimulated Incretin Response and Relationship With Structural Brain Outcomes in Aging and Alzheimer's Disease. Frontiers in Neuroscience. 14: 608862. PMID 33328877 DOI: 10.3389/fnins.2020.608862  0.124
2019 O'Bryant SE. Blood Biomarkers for Use in Alzheimer Disease-Moving From "If" to "How?" Jama Neurology. PMID 31233119 DOI: 10.1001/jamaneurol.2019.0845  0.123
2022 O'Bryant SE, Zhang F, Petersen M, Hall J, Johnson LA, Yaffe K, Braskie M, Rissman RA, Vig R, Toga AW. Neurodegeneration from the AT(N) framework is different among Mexican Americans compared to non-Hispanic Whites: A Health & Aging Brain among Latino Elders (HABLE) Study. Alzheimer's & Dementia (Amsterdam, Netherlands). 14: e12267. PMID 35155729 DOI: 10.1002/dad2.12267  0.123
2021 O'Bryant S, Petersen M, Hall J, Johnson L, Yaffe K, Braskie M, Toga AW, Rissman RA. Characterizing plasma NfL in a community-dwelling multi-ethnic cohort: Results from the HABLE study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34310015 DOI: 10.1002/alz.12404  0.107
2015 Doody RS, Demirovic J, Ballantyne CM, Chan W, Barber R, Powell S, Pavlik V, Doody R, Rountree S, Massman P, Darby E, Evans T, Khaleeq A, Schrimsher G, Dentino A, et al. Lipoprotein-associated phospholipase A2, homocysteine, and Alzheimer's disease Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. 1: 464-471. DOI: 10.1016/j.dadm.2015.08.001  0.104
2017 Robinson MD, Mishra I, Deodhar S, Patel V, Gordon KV, Vintimilla R, Brown K, Johnson L, O'Bryant S, Cistola DP. Water T2 as an early, global and practical biomarker for metabolic syndrome: an observational cross-sectional study. Journal of Translational Medicine. 15: 258. PMID 29258604 DOI: 10.1186/S12967-017-1359-5  0.101
2014 Gong G, Mattevada S, O'Bryant SE. Comparison of the accuracy of kriging and IDW interpolations in estimating groundwater arsenic concentrations in Texas. Environmental Research. 130: 59-69. PMID 24559533 DOI: 10.1016/j.envres.2013.12.005  0.1
2009 Gong G, Braddock E, Zhang Y, Hudson C, Lefforge D, O'Bryant S. Trend and racial disparities in infant mortality rate in Texas from 1990 to 2004 Journal of the National Medical Association. 101: 1149-1153. PMID 19998644  0.095
2012 Barber R, Xiao G, Wilhelmsen K, Huebinger R, Diaz-Arrastia R, O'Bryant S. P2-063: Comparison of protein concentrations in serum versus plasma from Alzheimer's patients Alzheimer's & Dementia. 8: P284-P284. DOI: 10.1016/j.jalz.2012.05.767  0.087
2014 Roane BM, Johnson L, Edwards M, Hall J, Al-Farra S, O'Bryant SE. The link between sleep disturbance and depression among Mexican Americans: a Project FRONTIER study. Journal of Clinical Sleep Medicine : Jcsm : Official Publication of the American Academy of Sleep Medicine. 10: 427-31. PMID 24733989 DOI: 10.5664/jcsm.3622  0.083
2012 Barber RC, Edwards MI, Xiao G, Huebinger RM, Diaz-Arrastia R, Wilhelmsen KC, Hall JR, O'Bryant SE. Serum granulocyte colony-stimulating factor and Alzheimer's disease. Dementia and Geriatric Cognitive Disorders Extra. 2: 353-60. PMID 23012618 DOI: 10.1016/J.Jalz.2011.05.910  0.075
Hide low-probability matches.